Frank van Leth1, Kirsten Evenblij2, Ferdinand Wit3, Albert Kiers4, Herman Sprenger5, Maurits Verhagen6, Mariska Hillebregt7, Nico Kalisvaart8, Henrieke Schimmel9, Annelies Verbon10. 1. Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. 2. Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. 3. Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 4. Municipal Public Health Service Fryslân, Leeuwarden, The Netherlands. 5. Department of Internal Medicine, Infectious Diseases Service, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 6. Municipal Public Health Service Limburg-Noord, Venlo, The Netherlands. 7. Stichting HIV Monitoring, Amsterdam, The Netherlands. 8. KNCV Tuberculosis Foundation, The Hague, The Netherlands. 9. National Institute for Public Health and Environment, Bilthoven, The Netherlands. 10. Department of Internal Medicine, Division of Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
Abstract
BACKGROUND: Knowledge of the HIV status in patients with tuberculosis (TB) and vice versa is crucial for proper individual patient management, while knowledge of the prevalence of co-infection guides preventive and therapeutic strategies. The aim of the study was to assess if national disease databases on TB and HIV are adequate sources to provide this information. METHODS: A two way capture-recapture analysis to assess the completeness of the registers, and to obtain the prevalence of TB-HIV co-infection in the Netherlands in the years 2002-2012. RESULTS: HIV testing was performed in less than 50% of the patients with TB. Of the 932 TB-HIV infected patients, just 293 (31.4%) were registered in both registers. Under-reporting of TB-HIV co-infection ranged from 50% to 70% in the national TB register, and from 31% to 37% in the HIV database. Prevalence of TB-HIV co-infection in the Netherlands in 2012 was 7.1% (95% CI 6.0% to 8.3%), which was more than double of the prevalence estimated from the national TB database. CONCLUSIONS: TB-HIV co-infection is markedly under-reported in national disease databases. There is an urgent need for improved registration and preferably a routine data exchange between the two surveillance systems. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Knowledge of the HIV status in patients with tuberculosis (TB) and vice versa is crucial for proper individual patient management, while knowledge of the prevalence of co-infection guides preventive and therapeutic strategies. The aim of the study was to assess if national disease databases on TB and HIV are adequate sources to provide this information. METHODS: A two way capture-recapture analysis to assess the completeness of the registers, and to obtain the prevalence of TB-HIV co-infection in the Netherlands in the years 2002-2012. RESULTS: HIV testing was performed in less than 50% of the patients with TB. Of the 932 TB-HIV infectedpatients, just 293 (31.4%) were registered in both registers. Under-reporting of TB-HIV co-infection ranged from 50% to 70% in the national TB register, and from 31% to 37% in the HIV database. Prevalence of TB-HIV co-infection in the Netherlands in 2012 was 7.1% (95% CI 6.0% to 8.3%), which was more than double of the prevalence estimated from the national TB database. CONCLUSIONS:TB-HIV co-infection is markedly under-reported in national disease databases. There is an urgent need for improved registration and preferably a routine data exchange between the two surveillance systems. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
PUBLIC HEALTH; SURVEILLANCE; TUBERCULOSIS
Authors: Daniel Eid; Miguel Guzman-Rivero; Ernesto Rojas; Isabel Goicolea; Anna-Karin Hurtig; Daniel Illanes; Miguel San Sebastian Journal: Am J Trop Med Hyg Date: 2018-01-01 Impact factor: 2.345
Authors: Katelynn Devinney; Julie Lazaroff; Jennifer B Rosen; Christopher M Zimmerman; Jane R Zucker Journal: Public Health Rep Date: 2020-04-08 Impact factor: 2.792
Authors: Tao Li; Lijia Yang; Sarah E Smith-Jeffcoat; Alice Wang; Hui Guo; Wei Chen; Xin Du; Hui Zhang Journal: Int J Environ Res Public Health Date: 2021-02-25 Impact factor: 3.390
Authors: Mustafa Al-Haboubi; Rebecca E Glover; Elizabeth Eastmure; Mark Petticrew; Nick Black; Nicholas Mays Journal: Antibiotics (Basel) Date: 2021-04-13
Authors: T Sonia Boender; Eline Op de Coul; Joop Arends; Maria Prins; Marc van der Valk; Jan T M van der Meer; Birgit van Benthem; Peter Reiss; Colette Smit Journal: Euro Surveill Date: 2020-02